We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More
Free Medical Devices WebinarsSign up to watch our free medical devices industry webinars. 
American medical devices company Visioneering Technologies (VTI) and ophthalmic products developer Lambda-X have developed customized software that can measure and illustrate the instantaneous and sagittal power curves of the NaturalVue Multifocal or any other multifocal lens.
Huawei has partnered with medical research bodies IIS Aragon and DIVE Medical to launch Track AI, an AI-powered assessment that detect and diagnose early signs of visual impairment in children.
LumiThera, a company developing treatment for ocular diseases, has started enrolling patients for LIGHTSITE II, a multi-center, clinical study for treating dry Age-Related Macular Degeneration (AMD) in Europe.
Eye care firm Alcon has been separated from Novartis and launched as an independent, publicly traded company to better serve its customers.
Lantheus, the parent company of Lantheus Medical Imaging, has collaborated with Cerevast Medical for treating retinal vein occlusion (RVO), a common cause of vision loss across the world.
Johnson & Johnson Vision has announced positive results from two phase 3 clinical studies evaluating investigational antihistamine-releasing contact lenses (etafilcon A with 0.019 mg ketotifen).
Swiss drugmaker Novartis has announced that it is planning to complete the 100% separation of its eye care business, Alcon, on 9 April 2025.
Innovative products of Seodong Medical Co., a leading dry eye syndrome treatment devices developer, are gaining significant popularity in Korea and other countries as they enhance health of eyeballs.
Novartis eye care division Alcon has acquired US-based medical device development firm PowerVision in a deal valued at around $285m.
Glaukos, an ophthalmic medical technology and pharmaceutical company, announced that results of an international glaucoma study published in the Journal of Cataract and Refractive Surgery showed use of iStent Trabecular Micro-Bypass Stent during cataract surgery delivered a 38% reduction in mean intraocular pressure (IOP) to 14.7 mmHg after five years of follow-up.
Get the Medical Devices newsletterSign up to our free email to get all the latest medical devices news.